Standard
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. / Lund, Søren S; Tarnow, Lise; Frandsen, Merete; Nielsen, Bente B; Hansen, Birgitte V; Pedersen, Oluf; Parving, Hans-Henrik; Vaag, Allan A.
In:
BMJ. British Medical Journal (International Ed.), Vol. 339, 2009, p. b4324.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Lund, SS, Tarnow, L, Frandsen, M, Nielsen, BB, Hansen, BV, Pedersen, O, Parving, H-H & Vaag, AA 2009, 'Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial', BMJ. British Medical Journal (International Ed.), vol. 339, pp. b4324.
APA
Lund, S. S., Tarnow, L., Frandsen, M., Nielsen, B. B., Hansen, B. V., Pedersen, O., Parving, H-H., & Vaag, A. A. (2009). Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. BMJ. British Medical Journal (International Ed.), 339, b4324.
Vancouver
Lund SS, Tarnow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O et al. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. BMJ. British Medical Journal (International Ed.). 2009;339:b4324.
Author
Lund, Søren S ; Tarnow, Lise ; Frandsen, Merete ; Nielsen, Bente B ; Hansen, Birgitte V ; Pedersen, Oluf ; Parving, Hans-Henrik ; Vaag, Allan A. / Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. In: BMJ. British Medical Journal (International Ed.). 2009 ; Vol. 339. pp. b4324.
Bibtex
@article{d883c46035ae11df8ed1000ea68e967b,
title = "Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial",
abstract = "OBJECTIVES: To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN: Randomised, double blind, double dummy, parallel trial. SETTING: Secondary care in Denmark between 2003 and 2006. PARTICIPANTS: Non-obese patients (BMI",
author = "Lund, {S{\o}ren S} and Lise Tarnow and Merete Frandsen and Nielsen, {Bente B} and Hansen, {Birgitte V} and Oluf Pedersen and Hans-Henrik Parving and Vaag, {Allan A}",
note = "Keywords: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobin A, Glycosylated; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Treatment Outcome; Weight Gain Export Date: 7 January 2010Source: Scopus",
year = "2009",
language = "English",
volume = "339",
pages = "b4324",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
}
RIS
TY - JOUR
T1 - Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
AU - Lund, Søren S
AU - Tarnow, Lise
AU - Frandsen, Merete
AU - Nielsen, Bente B
AU - Hansen, Birgitte V
AU - Pedersen, Oluf
AU - Parving, Hans-Henrik
AU - Vaag, Allan A
N1 - Keywords: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobin A, Glycosylated; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Treatment Outcome; Weight Gain
Export Date: 7 January 2010Source: Scopus
PY - 2009
Y1 - 2009
N2 - OBJECTIVES: To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN: Randomised, double blind, double dummy, parallel trial. SETTING: Secondary care in Denmark between 2003 and 2006. PARTICIPANTS: Non-obese patients (BMI
AB - OBJECTIVES: To study the effect of insulin treatment in combination with metformin or an insulin secretagogue, repaglinide, on glycaemic regulation in non-obese patients with type 2 diabetes. DESIGN: Randomised, double blind, double dummy, parallel trial. SETTING: Secondary care in Denmark between 2003 and 2006. PARTICIPANTS: Non-obese patients (BMI
M3 - Journal article
C2 - 19900993
VL - 339
SP - b4324
JO - The BMJ
JF - The BMJ
SN - 0959-8146
ER -
